Skip to main content
Careers
Offices
News
Events
Contact
Open menu
Close menu
People
All People
Lawyers & Agents
Other Legal Professionals
Law Students
Firm Leadership
Solutions
All Solutions
Industries
Practices
Innovations
Client Work
Markets
All Markets
Africa
Asia
Europe
United States
Knowledge
All Knowledge
Bulletins
Blog Posts
Podcasts
HR Space
Firm
About the Firm
Alumni Network
Equity, Diversity and Inclusion
Responsible Business
Reconciliation
Careers
Offices
News
Events
Contact
Portals
Alumni
Fasken Edge
Online Payment
What are you looking for?
Open portal menu
Close menu
Search
Close searchbar
Client Work
The agents in Valeo Pharma’s US$3.1 million public offering.
Fasken
Reading Time
1 minute read
Back
Home
Solutions
Client Work
The agents in Valeo Pharma’s US$3.1 million public offering.
Share
LinkedIn
Facebook
Twitter
Email
Print
PDF Form Input:
Save To PDF
Show QR Code
×
Overview
Overview
Client
Mackie Research Capital Corporation
Closed July 2019
Related Solutions
Related Solutions
Industries
Life Sciences
Practices
Capital Markets
Markets
Americas
Canada
Team
Team
John M. Sabetti, Partner | Mergers & Acquisitions, Toronto, ON, +1 416 865 4455, jsabetti@fasken.com
Alex Nikolic, Partner | Mergers & Acquisitions, Toronto, ON, +1 416 865 4420, anikolic@fasken.com
Rachel Phillips, Partner | Corporate/Commercial, Toronto, ON, +1 416 865 5154, rphillips@fasken.com
Mark Vanderveken, Associate | Life Sciences, Toronto, ON, +1 416 943 8927, mvanderveken@fasken.com
John M. Sabetti
Partner | Mergers & Acquisitions
Toronto, ON
+1 416 865 4455
jsabetti@fasken.com
Alex Nikolic
Partner | Mergers & Acquisitions
Toronto, ON
+1 416 865 4420
anikolic@fasken.com
Rachel Phillips
Partner | Corporate/Commercial
Toronto, ON
+1 416 865 5154
rphillips@fasken.com
Mark Vanderveken
Associate | Life Sciences
Toronto, ON
+1 416 943 8927
mvanderveken@fasken.com